Distributing effective SARS-CoV-2 medicines in a timely manner
- PMID: 35883227
- PMCID: PMC9353369
- DOI: 10.1002/jmv.28030
Distributing effective SARS-CoV-2 medicines in a timely manner
Conflict of interest statement
Noah Kojima recieved consulting fees from Curative. Vivek Desai is employed by Curative. Jeffrey D. Klausner serves as an independent Medical Director of Curative.
Figures
Comment on
-
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience.J Med Virol. 2022 Nov;94(11):5582-5588. doi: 10.1002/jmv.28011. Epub 2022 Aug 2. J Med Virol. 2022. PMID: 35855627 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
